Feasibility of plant-expression system for production of recombinant anti-human IgE: An alternative production platform for therapeutic monoclonal antibodies

Omalizumab, the anti-immunoglobulin IgE antibody is the only approved and available monoclonal antibody as an auxiliary medicament for the severe respiratory allergic reactions. It forms small size immune complexes by binding to free IgE, thereby inhibiting the interaction of IgE with its receptors....

Descripción completa

Detalles Bibliográficos
Autores principales: Hanittinan, Oranicha, Rattanapisit, Kaewta, Malla, Ashwini, Tharakhet, Kittipan, Ketloy, Chutitorn, Prompetchara, Eakachai, Phoolcharoen, Waranyoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Plant Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755585/
https://www.ncbi.nlm.nih.gov/pubmed/36531354
http://dx.doi.org/10.3389/fpls.2022.1012583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755585/
https://www.ncbi.nlm.nih.gov/pubmed/36531354
http://dx.doi.org/10.3389/fpls.2022.1012583

Ejemplares similares